Published in Drug Law Weekly, May 6th, 2008
Cephalon currently is reviewing the Notice Letter and, by statute, has 45 days to initiate a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.